{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T11:16:32Z","timestamp":1791112592432,"version":"4.1.0"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2013,6,6]],"date-time":"2013-06-06T00:00:00Z","timestamp":1370476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100010041","name":"Tianjin Municipal Science and Technology Commission","doi-asserted-by":"crossref","award":["07JCYBJC16500"],"award-info":[{"award-number":["07JCYBJC16500"]}],"id":[{"id":"10.13039\/501100010041","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100010041","name":"Tianjin Municipal Science and Technology Commission","doi-asserted-by":"crossref","award":["11JCZDJC19600"],"award-info":[{"award-number":["11JCZDJC19600"]}],"id":[{"id":"10.13039\/501100010041","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100010041","name":"Tianjin Municipal Science and Technology Commission","doi-asserted-by":"crossref","award":["11JCZDJC18600"],"award-info":[{"award-number":["11JCZDJC18600"]}],"id":[{"id":"10.13039\/501100010041","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["30901656"],"award-info":[{"award-number":["30901656"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,6,6]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>Mesenchymal stem cells (MSCs) are being explored extensively as a promising treatment for autoimmune diseases. We have recently reported that MSCs could ameliorate experimental autoimmune uveoretinitis (EAU) in rats. In this study, we examined further the effects of MSCs on the dynamics of T cell subsets in both eye and spleen and their cytokine production during the course of EAU. We focused on when and where the MSCs had inhibitory effects on T helper type 1 (Th1) and Th17 cells and how long the inhibitory effect lasted, in order to provide more mechanistic evidence for MSCs on the treatment of uveitis. Compared to the control group, administration of MSCs decreased the production of Th1 and Th17 cytokines significantly, while the production of Th2 and regulatory T cell (Treg) cytokines [interleukin (IL)-10 and transforming growth factor (TGF)-\u03b2] was elevated during the entire course of EAU. Correspondingly, the dynamic levels of IL-17 in the aqueous humour (AqH) were reduced in MSC-treated rats. Moreover, the ratio of Th17\/Treg cells in both spleen and eye was decreased. These results provide powerful evidence that MSCs can regulate negatively both Th1 and Th17 responses and restore the balance of Th17\/Tregs in the whole course of EAU, which is important for the regression of the disease.<\/jats:p>","DOI":"10.1111\/cei.12080","type":"journal-article","created":{"date-parts":[[2013,1,29]],"date-time":"2013-01-29T06:19:30Z","timestamp":1359440370000},"page":"28-37","source":"Crossref","is-referenced-by-count":51,"title":["The effect of mesenchymal stem cells on dynamic changes of T cell subsets in experimental autoimmune uveoretinitis"],"prefix":"10.1093","volume":"173","author":[{"given":"G","family":"Li","sequence":"first","affiliation":[{"name":"Tianjin Medical University Eye Hospital and Eye Institute, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Yuan","sequence":"additional","affiliation":[{"name":"Tianjin Medical University Eye Hospital and Eye Institute, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X","family":"Ren","sequence":"additional","affiliation":[{"name":"Tianjin Medical University Eye Hospital and Eye Institute, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Nian","sequence":"additional","affiliation":[{"name":"Tianjin Medical University Eye Hospital and Eye Institute, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Zhang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Experimental Haematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College (CAMS and PUMC), Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z C","family":"Han","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Experimental Haematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College (CAMS and PUMC), Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X","family":"Li","sequence":"additional","affiliation":[{"name":"Tianjin Medical University Eye Hospital and Eye Institute, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X","family":"Zhang","sequence":"additional","affiliation":[{"name":"Tianjin Medical University Eye Hospital and Eye Institute, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,6,6]]},"reference":[{"key":"2021122009553669400_cei12080-bib-0001","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1517\/14712598.2012.658366","article-title":"Biological agents for the treatment of uveitis","volume":"12","author":"Servat","year":"2012","journal-title":"Exp Opin Biol Ther"},{"key":"2021122009553669400_cei12080-bib-0002","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3727\/096368910X","article-title":"Mesenchymal stem cells","volume":"20","author":"Ding","year":"2011","journal-title":"Cell Transplant"},{"key":"2021122009553669400_cei12080-bib-0003","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s12015-009-9076-y","article-title":"Role of mesenchymal stem cells in immunological rejection of organ transplantation","volume":"5","author":"Zhang","year":"2009","journal-title":"Stem Cell Rev"},{"key":"2021122009553669400_cei12080-bib-0004","doi-asserted-by":"crossref","first-page":"574","DOI":"10.2174\/156652412800619950","article-title":"Immunosuppressive properties of mesenchymal stem cells: advances and applications","volume":"12","author":"De Miguel","year":"2012","journal-title":"Curr Mol Med"},{"key":"2021122009553669400_cei12080-bib-0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0897.2011.01069.x","article-title":"Immunomodulatory properties of mesenchymal stem cells: cytokines and factors","volume":"67","author":"Soleymaninejadian","year":"2012","journal-title":"Am J Reprod Immunol"},{"key":"2021122009553669400_cei12080-bib-0006","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1002\/art.27548","article-title":"Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus","volume":"62","author":"Sun","year":"2010","journal-title":"Arthritis Rheum"},{"key":"2021122009553669400_cei12080-bib-0007","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1136\/gut.2010.214841","article-title":"Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease","volume":"60","author":"Ciccocioppo","year":"2011","journal-title":"Gut"},{"key":"2021122009553669400_cei12080-bib-0008","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1586\/ern.11.113","article-title":"Harnessing the therapeutic potential of mesenchymal stem cells in multiple sclerosis","volume":"11","author":"Darlington","year":"2011","journal-title":"Exp Rev Neurother"},{"key":"2021122009553669400_cei12080-bib-0009","doi-asserted-by":"crossref","first-page":"R210","DOI":"10.1186\/ar3187","article-title":"Therapeutic potential of human umbilical cord mesenchymal stem cells in the treatment of rheumatoid arthritis","volume":"12","author":"Liu","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"2021122009553669400_cei12080-bib-0010","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1182\/blood-2011-11-391144","article-title":"Allogeneic mesenchymal stem cell treatment alleviates experimental and clinical Sjogren's syndrome","volume":"120","author":"Xu","year":"2012","journal-title":"Blood"},{"key":"2021122009553669400_cei12080-bib-0011","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/scrt75","article-title":"Mesenchymal stem cell effects on T-cell effector pathways","volume":"2","author":"Duffy","year":"2011","journal-title":"Stem Cell Res Ther"},{"key":"2021122009553669400_cei12080-bib-0012","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1089\/scd.2011.0157","article-title":"The role of mouse mesenchymal stem cells in differentiation of naive T-cells into anti-inflammatory regulatory T-cell or proinflammatory helper T-cell 17 population","volume":"21","author":"Svobodova","year":"2012","journal-title":"Stem Cells Dev"},{"key":"2021122009553669400_cei12080-bib-0013","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1164\/rccm.201001-0010OC","article-title":"Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis","volume":"182","author":"Mei","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"2021122009553669400_cei12080-bib-0014","first-page":"347","article-title":"Role of mesenchymal stem cells in neurogenesis and nervous system repair","volume":"59","author":"Maltman","year":"2011","journal-title":"Neurochem Int"},{"key":"2021122009553669400_cei12080-bib-0015","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1167\/iovs.10-6334","article-title":"Mesenchymal stem cells ameliorate experimental autoimmune uveoretinitis by comprehensive modulation of systemic autoimmunity","volume":"52","author":"Zhang","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2021122009553669400_cei12080-bib-0016","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1167\/iovs.11-8211","article-title":"Mesenchymal stem cells induce functionally active T regulatory lymphocytes in a paracrine fashion and ameliorate experimental autoimmune uveitis","volume":"53","author":"Tasso","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2021122009553669400_cei12080-bib-0017","first-page":"733","article-title":"Investigation of the role of mesenchymal stem cells on keratoplasty rejection","volume":"48","author":"Zhang","year":"2012","journal-title":"Chin J Ophthalmol"},{"key":"2021122009553669400_cei12080-bib-0018","doi-asserted-by":"crossref","DOI":"10.1002\/0471142735.im1506s53","article-title":"Experimental autoimmune uveoretinitis in the rat and mouse","author":"Caspi","year":"2003","journal-title":"Curr Protoc Immunol"},{"key":"2021122009553669400_cei12080-bib-0019","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0896-8411(03)00049-0","article-title":"Infiltration of the inflamed eye by NKT cells in a rat model of experimental autoimmune uveitis","volume":"21","author":"Shao","year":"2003","journal-title":"J Autoimmun"},{"key":"2021122009553669400_cei12080-bib-0020","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nm1585","article-title":"TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27\/STAT1","volume":"13","author":"Amadi-Obi","year":"2007","journal-title":"Nat Med"},{"key":"2021122009553669400_cei12080-bib-0021","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.jaci.2007.01.010","article-title":"IL-23 promotes CD4+ T cells to produce IL-17 in Vogt-Koyanagi-Harada disease","volume":"119","author":"Chi","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"2021122009553669400_cei12080-bib-0022","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1167\/iovs.07-1390","article-title":"Upregulated IL-23 and IL-17 in Beh\u00e7et patients with active uveitis","volume":"49","author":"Chi","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2021122009553669400_cei12080-bib-0023","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1084\/jem.20071258","article-title":"Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category","volume":"205","author":"Luger","year":"2008","journal-title":"J Exp Med"},{"key":"2021122009553669400_cei12080-bib-0024","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1749-6632.2009.05133.x","article-title":"Th1 and Th17 cells: adversaries and collaborators","volume":"1183","author":"Damsker","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"2021122009553669400_cei12080-bib-0025","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1089\/jir.2011.0042","article-title":"Cytokines in autoimmune uveitis","volume":"31","author":"Horai","year":"2011","journal-title":"J Interferon Cytokine Res"},{"key":"2021122009553669400_cei12080-bib-0026","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1167\/iovs.07-1468","article-title":"Ocular regulatory T cells distinguish monophasic from recurrent autoimmune uveitis","volume":"49","author":"Ke","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2021122009553669400_cei12080-bib-0027","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1167\/iovs.09-3514","article-title":"Contribution of CD4+CD25+ T cells to the regression phase of experimental autoimmune uveoretinitis","volume":"51","author":"Sun","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2021122009553669400_cei12080-bib-0028","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.1167\/iovs.08-1793","article-title":"Diminished frequency and function of CD4+CD25high regulatory T cells associated with active uveitis in Vogt\u2013Koyanagi\u2013Harada syndrome","volume":"49","author":"Chen","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2021122009553669400_cei12080-bib-0029","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature04753","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells","volume":"441","author":"Bettelli","year":"2006","journal-title":"Nature"},{"key":"2021122009553669400_cei12080-bib-0030","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/nature06878","article-title":"TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function","volume":"453","author":"Zhou","year":"2008","journal-title":"Nature"},{"key":"2021122009553669400_cei12080-bib-0031","doi-asserted-by":"crossref","first-page":"18460","DOI":"10.1073\/pnas.0809850105","article-title":"IL-6 controls Th17 immunity in vivo by inhibiting the conversion of conventional T cells into Foxp3+ regulatory T cells","volume":"105","author":"Korn","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021122009553669400_cei12080-bib-0032","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.2337\/db11-0090","article-title":"Expansion of Th17 cells and functional defects in T regulatory cells are key features of the pancreatic lymph nodes in patients with type 1 diabetes","volume":"60","author":"Ferraro","year":"2011","journal-title":"Diabetes"},{"key":"2021122009553669400_cei12080-bib-0033","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1007\/s00296-011-1984-x","article-title":"Disturbed Th17\/Treg balance in patients with rheumatoid arthritis","volume":"32","author":"Niu","year":"2012","journal-title":"Rheumatol Int"},{"key":"2021122009553669400_cei12080-bib-0034","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.clim.2011.03.014","article-title":"Th17 and Treg balance in systemic sclerosis","volume":"139","author":"Khoury","year":"2011","journal-title":"Clin Immunol"},{"key":"2021122009553669400_cei12080-bib-0035","doi-asserted-by":"crossref","first-page":"144","DOI":"10.2174\/1574888X11308020005","article-title":"Mesenchymal stem cells derived from Wharton's jelly of the umbilical cord: biological properties and emerging clinical applications","volume":"8","author":"Batsali","year":"2013","journal-title":"Curr Stem Cell Res Ther"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcei.12080","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/173\/1\/28\/41787825\/cei12080.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/173\/1\/28\/41787825\/cei12080.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T11:24:30Z","timestamp":1641036270000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/173\/1\/28\/6420978"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,6]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2013,6,6]]},"published-print":{"date-parts":[[2013,6,6]]}},"URL":"https:\/\/doi.org\/10.1111\/cei.12080","relation":{},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"value":"1365-2249","type":"electronic"},{"value":"0009-9104","type":"print"}],"subject":[],"published-other":{"date-parts":[[2013,7]]},"published":{"date-parts":[[2013,6,6]]}}}